Mark Reynolds - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mark Reynolds

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Journal of Substance Abuse Treatment|June 11, 2014

A performance measure for continuity of care after detoxification: relationship with outcomesMargaret T Lee, Constance M Horgan, Deborah W Garnick, et al.

The Lancet. Oncology|April 3, 2018

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.

Blood|May 10, 2015

The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse modelMatthew D Blunt, Matthew J Carter, Marta Larrayoz, et al.

British Journal of Cancer|September 18, 2018

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.

Biological Reviews of the Cambridge Philosophical Society|June 2, 2017

Managing consequences of climate-driven species redistribution requires integration of ecology, conservation and social scienceTimothy C Bonebrake, Christopher J Brown, Johann D Bell, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Journal of Substance Abuse Treatment|June 11, 2014

A performance measure for continuity of care after detoxification: relationship with outcomesMargaret T Lee, Constance M Horgan, Deborah W Garnick, et al.

The Lancet. Oncology|April 3, 2018

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.

Blood|May 10, 2015

The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse modelMatthew D Blunt, Matthew J Carter, Marta Larrayoz, et al.

British Journal of Cancer|September 18, 2018

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade gliomaDavid S Ziegler, Marie Wong, Chelsea Mayoh, et al.

Biological Reviews of the Cambridge Philosophical Society|June 2, 2017

Managing consequences of climate-driven species redistribution requires integration of ecology, conservation and social scienceTimothy C Bonebrake, Christopher J Brown, Johann D Bell, et al.

Pageof 5